AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $113,000 | +82.3% | 15,000 | 0.0% | 0.01% | +80.0% |
| Q3 2019 | $62,000 | +44.2% | 15,000 | 0.0% | 0.01% | +66.7% |
| Q2 2019 | $43,000 | +95.5% | 15,000 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $22,000 | +214.3% | 15,000 | +9159.3% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | -89.4% | 162 | -98.9% | 0.00% | -80.0% |
| Q3 2018 | $66,000 | -38.3% | 15,000 | 0.0% | 0.01% | -44.4% |
| Q2 2018 | $107,000 | 0.0% | 15,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $107,000 | -13.0% | 15,000 | 0.0% | 0.01% | -18.2% |
| Q4 2017 | $123,000 | -60.8% | 15,000 | -50.0% | 0.01% | -42.1% |
| Q3 2017 | $314,000 | -4.8% | 30,000 | 0.0% | 0.02% | -13.6% |
| Q2 2017 | $330,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |